Unveiling the therapeutic potential of Farnesol against Parkinson's disease: insights from molecular Docking and animal studies.
Background: Parkinson's disease (PD) is a chronic neurodegenerative disorder that progressively worsens over an individual's lifetime. Current treatments primarily address the symptoms rather than the underlying cause of the disease, and many patients report adverse side effects from the medications...
| Publicado en: | DARU: Journal of Pharmaceutical Sciences Vol. 34; no. 1; pp. 1 - 14 |
|---|---|
| Autores principales: | , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Springer Nature
2/14/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |